Comparison of cause distribution between elderly and non-elderly patients with chronic cough

Respiration

Volumn 77, Issue 3, 2009, Pages 259-264

  Wei, Weili ^a   Yu, Li ^a   Lü, Hanjing ^a   Wang, Lan ^a   Shi, Cuiqin ^a   Ma, Wei ^a   Huang, Yang ^a   Qiu, Zhongmin ^a  

^a TONGJI UNIVERSITY   (China)

Author keywords

Angiotensin converting enzyme inhibitors; Chronic cough; Cough variant asthma; Gastroesophageal reflux disease; Upper airway cough syndrome

Indexed keywords

CETIRIZINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPROPHYLLINE; DOMPERIDONE; MACROLIDE; OMEPRAZOLE; TERBUTALINE;

ADULT; AGED; ARTICLE; ASTHMA; CHINA; CHRONIC SINUSITIS; COUGH VARIANT ASTHMA; COUGHING; DRUG WITHDRAWAL; FEMALE; GASTROESOPHAGEAL REFLUX; GERIATRIC PATIENT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY TRACT DISEASE; SPUTUM CYTODIAGNOSIS; UPPER AIRWAY COUGH SYNDROME;

ADULT; AGE FACTORS; AGED; COUGH; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 64349124682     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000142942     Document Type: Article

References (66)

1. French CT, Irwin RS, Fletcher KE, Adams TM: Evaluation of a cough-specific qualityof- life questionnaire. Chest 2002; 121: 1123-1131.
2. Irwin RS, Curley FJ, French CL: Chronic cough: the spectrum and frequency of causes, key components of diagnostic evaluation, and outcome of specific therapy. Am Rev Respir Dis 1990; 141: 640-647.
3. Irwin RS, Boulet LP, Cloutier MM, Fuller R, Gold PM, Hoffstein V, Ing AJ, McCool FD, O'Byrne P, Poe RH, Prakash UB, Pratter MR, Rubin BK: Managing cough as a defense mechanism and as a symptom. A consensus panel report of the American College of Chest Physicians. Chest 1998; 114: 133S- 181S.
4. Brightling CE, Ward R, Goh KL, Wardlaw AJ, Pavord ID: Eosinophilic bronchitis is an important cause of chronic cough. Am J Respir Crit Care Med 1999; 160: 406-410.
5. Marchant JM, Masters IB, Taylor SM, Cox NC, Seymour GJ, Chang AB: Evaluation and outcome of young children with chronic cough. Chest 2006; 29: 1132-1141.
6. Morice AH, Fontana GA, Sovijarvi AR, Pistolesi M, Chung KF, Widdicombe J, O'Connell F, Geppetti P, Gronke L, De Jongste J, Belvisi M, Dicpinigaitis P, Fischer A, McGarvey L, Fokkens WJ, Kastelik J, ERS Task Force: The diagnosis and management of chronic cough. Eur Respir J 2004; 24: 481-492.
7. Pratter MR: Chronic upper airway cough syndrome secondary to rhinosinus diseases (previously referred to as postnasal drip syndrome): ACCP evidence-based clinical practice guidelines. Chest 2006; 129: 63S-71S.
8. Iredale MJ, Wanklyn SA, Phillips IP, Krausz T, Ind PW: Non-invasive assessment of bronchial inflammation in asthma: no correlation between eosinophilia of induced sputum and bronchial responsiveness to inhaled hypertonic saline. Clin Exp Allergy 1994; 24: 940-945.
9. Respiratory Section of Chinese Medical Association: Guidelines for the diagnosis and management of asthma (in Chinese). Chin J Tuberc Respir Dis 1997; 20: 261-267.
10. Kastelik JA, Jackson W, Davies TW, Wright GA, Redington AE, Wedgwood KR, Morice AH: Measurement of gastric emptying in gastroesophageal reflux-related chronic cough. Chest 2002; 122: 2038-2041.
11. Hsu JY, Stone RA, Logan-Sinclair RB, Worsdell M, Busst CM, Chung KF: Coughing frequency in patients with persistent cough: assessment using a 24 hour ambulatory recorder. Eur Respir J 1994; 7: 1246-1253.
12. Yu L, Qiu Z, Lü H, Wei W, Shi C: Clinical benefit of a sequential three-step empiric therapy in the management of chronic cough. Respirology 2008; 13: 353-358.
13. Irwin RS, Madison JM: The persistently troublesome cough. Am J Respir Crit Care Med 2002; 165: 1469-1474.
14. Yang ZM, Qiu ZM, Lv HJ, Wei WL, Wang L, Liu RL: A prospective study on the causes of chronic cough (in Chinese). J Tong Ji Univ (Med Sci) 2005; 26: 62-64.
15. Palombini BC, Villanova CA, Araújo E, Gastal OL, Alt DC, Stolz DP, Palombini CO: A pathogenic triad in chronic cough: asthma, postnasal drip syndrome, and gastroesophageal reflux disease. Chest 1999; 116: 279-284.
16. Bosch J, Lonn E, Pogue J, Arnold JM, Dagenais GR, Yusuf S: Long-term effects of ramipril on cardiovascular events and on diabetes: results of the HOPE study extension. Circulation 2005; 112: 1339-1346.
17. Israili ZH, Hall WD: Cough and angioneurotic edema associated with angiotensinconverting enzyme inhibitor therapy. A review of the literature and pathophysiology. Ann Intern Med 1992; 117: 234-242.
18. Wong ND, Thakral G, Franklin SS, L'Italien GJ, Jacobs MJ, Whyte JL, Lapuerta P: Preventing heart disease by controlling hypertension: impact of hypertensive subtype, stage, age, and sex. Am Heart J 2003; 145: 888-895.
19. Irwin RS, Curly FJ, French CL, Zawacki JK, Bennett FM: Chronic cough due to gastrooesophageal reflux. Clinical, diagnostic and pathogenetic aspect. Chest 1993; 104: 1511-1517.
20. Irwin RS: Chronic cough due to gastroesophageal reflux disease: ACCP evidencebased clinical practice guidelines. Chest 2006; 129: 80S-94S.
21. Patterson RN, Johnston BT, MacMahon J, Heaney LG, McGarvey LP: Oesophageal pH monitoring is of limited value in the diagnosis of 'reflux-cough'. Eur Respir J 2004; 24: 724-727.
22. Sifrim D, Dupont L, Blondeau K, Zhang X, Tack J, Janssens J: Weakly acidic reflux in patients with chronic unexplained cough during
23. hour pressure, pH, and impedance monitoring. Gut 2005; 54: 449-454.
24. Pratter MR, Bartter T, Akers S, DuBois J: An algorithmic approach to chronic cough. Ann Intern Med 1993; 119: 977-983.
25. Matsumoto H, Niimi A, Takemura M, Ueda T, Yamaguchi M, Matsuoka H, Jinnai M, Chin K, Mishima M: Prevalence and clinical manifestations of gastro-oesophageal reflux- associated chronic cough in the Japanese population. Cough 2007; 3: 1.
26. Wong BC, Kinoshita Y: Systematic review on epidemiology of gastroesophageal reflux disease in Asia. Clin Gastroenterol Hepatol 2006; 4: 398-407.
27. Vandenplas Y, Hassall E: Mechanisms of gastroesophageal reflux and gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr 2002; 35: 119-136.
28. Irwin RS, French CL, Smyrnios NA, Curley FJ: Interpretation of positive results of a methacholine inhalation challenge and 1 week of inhaled bronchodilator use in diagnosing and treating cough-variant asthma. Arch Intern Med 1997; 157: 1981-1987.
29. Fujimura M, Ogawa H, Nishizawa Y, Nishi K: Comparison of atopic cough with cough variant asthma: is atopic cough a precursor of asthma? Thorax 2003; 58: 14-18.
30. Nakajima T, Nishimura Y, Nishiuma T, Kotani Y, Funada Y, Nakata H, Yokoyama M: Characteristics of patients with chronic cough who developed classic asthma during the course of cough variant asthma: a longitudinal study. Respiration 2005; 72: 606-611.
31. Fujimura M, Hara J, Myou S: Change in bronchial responsiveness and cough reflex sensitivity in patients with cough variant asthma: effect of inhaled corticosteroids. Cough 2005; 1: 5. 265-272
32. Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM: Global burden of COPD: systematic review and meta-analysis. Eur Respir J 2006; 28: 523-532.
33. American Thoracic Society: Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152:s77-s121.
34. Chung KF, Adcock IM: Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction. Eur Respir J 2008; 31: 1334-1356.
35. Holgate ST: Pathogenesis of asthma. Clin Exp Allergy 2008; 38: 872-897.
36. Fabbri LM, Romagnoli M, Corbetta L, Casoni G, Busljetic K, Turato G, Ligabue G, Ciaccia A, Saetta M, Papi A: Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 167: 418-424.
37. Keatings VM, Collins PD, Scott DM, Barnes PJ: Differences in interleukin-8 and tumor necrosis factor- ß in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996; 153: 530-534.
38. Keatings VM, Barnes PJ: Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma, and normal subjects. Am J Respir Crit Care Med 1997; 155: 449-453.
39. Burrows B, Bloom JW, Traver GA, Cline MG: The course and prognosis of different forms of chronic airways obstruction in a sample from the general population. N Engl J Med 1987; 317: 1309-1314.
40. Boschetto P, Miniati M, Miotto D, Braccioni F, De Rosa E, Bononi I, Papi A, Saetta M, Fabbri LM, Mapp CE: Predominant emphysema phenotype in chronic obstructive pulmonary disease patients. Eur Respir J 2003; 21: 450-454.
41. Boschetto P, Quintavalle S, Zeni E, Leprotti S, Potena A, Ballerin L, Papi A, Palladini G, Luisetti M, Annovazzi L, Iadarola P, De Rosa E, Fabbri LM, Mapp CE: Association between markers of emphysema and more severe chronic obstructive pulmonary disease. Thorax 2006; 61: 1037-1042.
42. Papi A, Romagnoli M, Baraldo S, Braccioni F, Guzzinati I, Saetta M, Ciaccia A, Fabbri LM: Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 162: 1773-1777.
43. Paggiaro PL, Chanez P, Holz O, Ind PW, Djukanović R, Maestrelli P, Sterk PJ: Sputum induction. Eur Respir J Suppl 2002; 37: 3s-8s.
44. Cianchetti S, Bacci E, Bartoli ML, Ruocco L, Pavia T, Dente FL, Di Franco A, Vagaggini B, Paggiaro P: Can hypertonic saline inhalation influence preformed chemokine and mediator release in induced sputum of chronic obstructive pulmonary disease patients? Comparison with isotonic saline. Clin Exp Allergy 2007; 37: 1819-1826.
45. Bacci E, Cianchetti S, Carnevali S, Bartoli ML, Dente FL, Di Franco A, Giannini D, Vagaggini B, Paggiaro PL: Induced sputum is a reproducible method to assess airway inflammation in asthma. Mediators Inflamm 2002; 11: 293-298.
46. Lacoste JY, Bousquet J, Chanez P, Van Vyve T, Simony-Lafontaine J, Lequeu N, Vic P, Enander I, Godard P, Michel FB: Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease. J Allergy Clin Immunol 1993; 92: 537-548.
47. Leckie MJ, Jenkins GR, Khan J, Smith SJ, Walker C, Barnes PJ, Hansel TT: Sputum T lymphocytes in asthma, COPD and healthy subjects have the phenotype of activated intraepithelial T cells (CD69+ CD103+). Thorax 2003; 58: 23-29.
48. Dente FL, Carnevali S, Bartoli ML, Cianchetti S, Bacci E, Di Franco A, Vagaggini B, Paggiaro P: Profiles of proinflammatory cytokines in sputum from different groups of severe asthmatic patients. Ann Allergy Asthma Immunol 2006; 97: 312-320.
49. Little SA, MacLeod KJ, Chalmers GW, Love JG, McSharry C, Thomson NC: Association of forced expiratory volume with disease duration and sputum neutrophils in chronic asthma. Am J Med 2002; 112: 446-452.
50. Balzano G, Stefanelli F, Iorio C, De Felice A, Melillo EM, Martucci M, Melillo GL: Eosinophilic inflammation in stable chronic obstructive pulmonary disease. Relationship with neutrophils and airway function. Am J Respir Crit Care Med 1999; 160: 1486-1492.
51. Zhu J, Qiu YS, Majumdar S, Gamble E, Matin D, Turato G, Fabbri LM, Barnes N, Saetta M, Jeffery PK: Exacerbations of bronchitis: bronchial eosinophilia and gene expression for interleukin-4, interleukin-5, and eosinophil chemoattractants. Am J Respir Crit Care Med 2001; 164: 109-116.
52. Spanevello A, Confalonieri M, Sulotto F, Romano F, Balzano G, Migliori GB, Bianchi A, Michetti G: Induced sputum cellularity. Reference values and distribution in normal volunteers. Am J Respir Crit Care Med 2000; 162: 1172-1174.
53. Fujimoto K, Kubo K, Yamamoto H, Yamaguchi S, Matsuzawa Y: Eosinophilic inflammation in the airway is related to glucocorticoid reversibility in patients with pulmonary emphysema. Chest 1999; 115: 697-702.
54. Chanez P, Vignola AM, O'Shaugnessy T, Enander I, Li D, Jeffery PK, Bousquet J: Corticosteroid reversibility in COPD is related to features of asthma. Am J Respir Crit Care Med 1997; 155: 1529-1534.
55. Beeh KM, Kornmann O, Buhl R, Culpitt SV, Giembycz MA, Barnes PJ: Neutrophil chemotactic activity of sputum from patients with COPD: role of interleukin 8 and leukotriene B 4 . Chest 2003; 123: 1240-1247.
56. Milne ENC, Pistolesi M: Detecting and quantifying chronic bronchitis and emphysema; in Milne ENC, Pistolesi M (eds): Reading the Chest Radiograph. A Physiologic Approach. St Louis, Mosby, 1993, pp 267-310.
57. Miniati M, Filippi E, Falaschi F, Carrozzi L, Milne EN, Sostman HD, Pistolesi M: Radiologic evaluation of emphysema in patients with chronic obstructive pulmonary disease. Chest radiography versus high-resolution computed tomography. Am J Respir Crit Care Med 1995; 151: 1359-1367.
58. Sitkauskiene B, Sakalauskas R, Malakauskas K, Lotvall J: Reversibility to a ß 2 -agonist in COPD: relationship to atopy and neutrophil activation. Respir Med 2003; 97: 591-598.
59. Kostikas K, Gaga M, Papatheodorou G, Karamanis T, Orphanidou D, Loukides S: Leukotriene B 4 in exhaled breath condensate and sputum supernatant in patients with COPD and asthma. Chest 2005; 127: 1553-1559.
60. Calverley PM, Burge PS, Spencer S, Anderson JA, Jones PW: Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax 2003; 58: 659-664.
61. Fabbri L, Pauwels RA, Hurd SS: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD Executive Summary updated 2003. COPD 2004; 1: 105-141.
62. Confalonieri M, Mainardi E, Della Porta R, Bernorio S, Gandola L, Beghè B, Spanevello A: Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonary disease. Thorax 1998; 53: 583-585.
63. Yildiz F, Kaur AC, Ilgazli A, Celikoglu M, Kacar Ozkara S, Paksoy N, Ozkarakas O: Inhaled corticosteroids may reduce neutrophilic inflammation in patients with stable chronic obstructive pulmonary disease. Respiration 2000; 67: 71-76.
64. Keatings VM, Jatakanon A, Worsdell YM, Barnes PJ: Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am J Respir Crit Care Med 1997; 155: 542-548.
65. Liu J, Sandrini A, Thurston MC, Yates DH, Thomas PS: Nitric oxide and exhaled breath nitrite/nitrates in chronic obstructive pulmonary disease patients. Respiration 2007; 74: 617-623.
66. Snoeck-Stroband JB, Lapperre TS, Gosman MM, Boezen HM, Timens W, ten Hacken NH, Sont JK, Sterk PJ, Hiemstra PS; Groningen Leiden Universities Corticosteroids in Obstructive Lung Disease (GLUCOLD) Study Group: Chronic bronchitis sub-phenotype within COPD: inflammation in sputum and biopsies. Eur Respir J 2008; 31: 70-77.